JAZZ

Jazz Pharmaceuticals (JAZZ)

About Jazz Pharmaceuticals (JAZZ)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Details

Daily high

$230.00

Daily low

$223.34

Price at open

$228.73

52 Week High

$230.40

52 Week Low

$99.13

Market cap

14.2B

Dividend yield

0.00%

Volume

741,275

Avg. volume

998,488

P/E ratio

-12,271.20

Jazz Pharmaceuticals News